SCHEMBL1667453

SCHEMBL1667453

CCCOCC1(c2ccccc2)CO1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 3/20 0.39
CHRM2 P08172 3/20 0.38
CHRM1 P11229 3/20 0.38
ADRA1D P25100 1/20 0.36
OPRM1 P35372 1/20 0.35
OPRD1 P41143 1/20 0.35
OPRK1 P41145 1/20 0.35
OPRL1 P41146 1/20 0.35
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
DRD3 P35462 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
LMNA P02545 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ASGR1 P07306 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2729452 0.86 HTR1A (0.38) HTR1ACHRM2CHRM1ADRA1DOPRM1
SCHEMBL11702282 0.85 HTR1A (0.38) HTR1ACHRM2CHRM1ADRA1DL3MBTL1
SCHEMBL1692140 0.78 HTR1A (0.40) HTR1ACHRM2CHRM1ADRA1DOPRM1
SCHEMBL10812665 0.76 KDM1A (0.38) HTR1ACHRM2CHRM1OPRM1OPRK1
SCHEMBL27885042 0.76 KDM1A (0.38) HTR1ACHRM2CHRM1OPRM1OPRK1
SCHEMBL6493726 0.75 MEN1 (0.40) HTR1ACHRM2CHRM1OPRM1OPRK1
SCHEMBL6493723 0.75 MEN1 (0.40) HTR1ACHRM2CHRM1OPRM1OPRK1
SCHEMBL11140706 0.73 OPRM1 (0.46) HTR1AOPRM1OPRD1OPRK1OPRL1
SCHEMBL11264607 0.73 HTR1A (0.48) HTR1AADRA1DRECQLTDP1
SCHEMBL379441 0.70 MMP2 (0.47) OPRM1OPRD1OPRK1OPRL1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012046882-A1 1,4-OXAZEPANE DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-04-12 WO disclosed